| 000 | 01017 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515015629.0 | ||
| 264 | 0 | _c20060504 | |
| 008 | 200605s 0 0 eng d | ||
| 022 | _a1535-7163 | ||
| 024 | 7 |
_a10.1158/1535-7163.MCT-05-0420 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aModrak, David E | |
| 245 | 0 | 0 |
_aSphingolipid targets in cancer therapy. _h[electronic resource] |
| 260 |
_bMolecular cancer therapeutics _cFeb 2006 |
||
| 300 |
_a200-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
| 650 | 0 | 4 | _aCell Death |
| 650 | 0 | 4 |
_aCeramides _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aSphingolipids _xanalysis |
| 700 | 1 | _aGold, David V | |
| 700 | 1 | _aGoldenberg, David M | |
| 773 | 0 |
_tMolecular cancer therapeutics _gvol. 5 _gno. 2 _gp. 200-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1535-7163.MCT-05-0420 _zAvailable from publisher's website |
| 999 |
_c16115692 _d16115692 |
||